Further, when bleeding risk was assessed between apixaban and dabigatran, dabigatran had a 41% greater risk than apixaban for a major bleed (HR 1.41 [95% CI 0.93–2.14]) but did not reach statistical significance [ 20 ].
← all excerpts
Elderly Bleeding Risk of Direct Oral Anticoagulants in Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Cohort Studies.
1
—
—